Seven Eight Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,154
Closed -$1.08M 190
2024
Q3
$1.08M Buy
11,154
+8,330
+295% +$749K 0.1% 369
2024
Q2
$242K Buy
+2,824
New +$237K 0.03% 637
2021
Q4
Sell
-12,146
Closed -$725K 527
2021
Q3
$725K Sell
12,146
-1,555
-11% -$97.8K 0.07% 361
2021
Q2
$851K Buy
+13,701
New +$913K 0.12% 302
2020
Q4
Sell
-9,428
Closed -$487K 469
2020
Q3
$487K Buy
+9,428
New +$484K 0.11% 348
2020
Q1
Sell
-48,520
Closed -$2.67M 519
2019
Q4
$2.67M Buy
48,520
+11,187
+30% +$607K 0.14% 226
2019
Q3
$1.88M Sell
37,333
-31,676
-46% -$1.59M 0.1% 303
2019
Q2
$3.48M Buy
69,009
+16,341
+31% +$793K 0.18% 161
2019
Q1
$2.45M Buy
52,668
+18,855
+56% +$955K 0.13% 206
2018
Q4
$1.66M Buy
33,813
+4,776
+16% +$272K 0.09% 274
2018
Q3
$1.8M Buy
+29,037
New +$1.77M 0.11% 266
2018
Q1
Sell
-40,727
Closed -$1.6M 409
2017
Q4
$1.6M Buy
+40,727
New +$1.55M 0.16% 214
2016
Q2
Sell
-15,587
Closed -$467K 568
2016
Q1
$467K Buy
+15,587
New +$430K 0.2% 164

Other funds holding EHC

Seven Eight Capital's EHC Position: Q4 2024 in Review

Seven Eight Capital sold out of Encompass Health (EHC) in Q4 2024, closing a stake of 11,154 shares — an estimated $1.08M sold.

Seven Eight Capital first reported a position in EHC in Q1 2016 and held it in 13 quarters. The position peaked at $3.48M in Q2 2019. 544 funds tracked by Wall St. Rank hold EHC as of Q4 2024.

  • Seven Eight Capital reported no remaining Encompass Health position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 11,154 Encompass Health shares in Q4 2024, an estimated $1.08M.
  • Seven Eight Capital first reported a position in Encompass Health in Q1 2016 and held it in 13 quarters.
  • Seven Eight Capital's Encompass Health position peaked at $3.48M in Q2 2019.
  • 544 funds tracked by Wall St. Rank held Encompass Health as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.